The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion

Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.

from Health and Science https://ift.tt/XIBNSlE
https://ift.tt/IZsVCRL
https://ift.tt/Cv4szEa